腹部脂肪抽吸对心脏淀粉样变性的诊断敏感性
该研究在600例连续确诊的心脏淀粉样变性患者中评估腹部脂肪垫细针抽吸(FPFNA)的诊断敏感性。结果显示,心脏AL淀粉样变性患者中FPFNA的敏感性为84%,且随全身淀粉样负荷增大而升高(P<0.001);ATTRm和ATTRwt患者中敏感性分别为45%和15%。结论认为FPFNA在心脏AL淀粉样变性中具有合理敏感性,尤其在全身负荷大时。
要点
- FPFNA在心脏AL淀粉样变性中敏感性为84%,全身负荷大者可达100%。
- FPFNA在ATTRm和ATTRwt心脏淀粉样变性中敏感性较低,分别为45%和15%。
- FPFNA有时可避免心内膜心肌活检,尤其适用于全身负荷大的AL型患者。
核心结论
- FPFNA在心脏AL淀粉样变性中具有合理的诊断敏感性,尤其适用于全身淀粉样负荷大的患者。
- 在转甲状腺素蛋白心脏淀粉样变性中FPFNA敏感性显著较低,尤其ATTRwt型,但有时仍可避免心内膜心肌活检。
研究设计与样本
- 单中心连续纳入600例确诊心脏淀粉样变性患者,其中AL型216例、ATTRm型113例、ATTRwt型271例。
- 通过刚果红染色腹部脂肪垫细针抽吸标本评估淀粉样沉积,并以血清淀粉样P成分(SAP)闪烁扫描评估全身淀粉样负荷。
主要发现
- 心脏AL淀粉样变性患者中,FPFNA刚果红染色检出淀粉样沉积的敏感性为84%(181/216)。
- AL型患者中,全身淀粉样负荷大、中、小者的FPFNA敏感性分别为100%、97%和78%(P<0.001)。
- FPFNA沉积物通过免疫组化成功分型为AL的病例占47%(102/216)。
- ATTRm心脏淀粉样变性患者中FPFNA检出淀粉样沉积的敏感性为45%(51/113)。
- ATTRwt心脏淀粉样变性患者中FPFNA检出淀粉样沉积的敏感性仅为15%(42/271)。
临床怎么用
- 对于怀疑心脏AL淀粉样变性且全身淀粉样负荷大的患者,可考虑先行FPFNA以辅助诊断。
- FPFNA在ATTR型心脏淀粉样变性中敏感性低,阴性结果不能排除诊断,尤其ATTRwt型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Congo red staining of an endomyocardial biopsy is the diagnostic gold-standard in suspected cardiac amyloidosis (CA), but the procedure is associated with the risk, albeit small, of serious complications, and delay in diagnosis due to the requirement for technical expertise. In contrast, abdominal fat pad fine needle aspiration (FPFNA) is a simple, safe and well-established procedure in systemic amyloidosis, but its diagnostic sensitivity in patients with suspected CA remains unclear. METHODS AND RESULTS: We assessed the diagnostic sensitivity of FPFNA in 600 consecutive patients diagnosed with CA [216 AL amyloidosis, 113 hereditary transthyretin (ATTRm), and 271 wild-type transthyretin (ATTRwt) amyloidosis] at our Centre. Amyloid was detected on Congo red staining of FPFNAs in 181/216 (84%) patients with cardiac AL amyloidosis, including 100, 97, and 78% of those with a large, moderate, and small whole-body amyloid burden, respectively, as assessed by serum amyloid P (SAP) component scintigraphy (P < 0.001); the deposits were successfully typed as AL by immunohistochemistry in 102/216 (47%) cases. Amyloid was detected in FPFNAs of 51/113 (45%) patients with ATTRm CA, and only 42/271 (15%) cases with ATTRwt CA. CONCLUSIONS: FPFNA has reasonable diagnostic sensitivity in cardiac AL amyloidosis, particularly in patients with a large whole-body amyloid burden. Although the diagnostic sensitivity of FPFNA is substantially lower in transthyretin CA, particularly ATTRwt, it may nevertheless sometimes obviate the need for endomyocardial biopsy.
引用
- Quarta CC, Gonzalez-Lopez E, Gilbertson JA, et al. Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis. Eur Heart J. 2017. PMID: 28605421. doi:10.1093/eurheartj/ehx047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。